Knockdown of SRSF1 can reduce the expression level of full-length MYO1B protein in both drug-resistant and parental breast cancer cells, indicating that SRSF1 regulated the alternative splicing of MYO1B in breast cancer cells. Here, MYO1B is linked to breast carcinoma.